Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-021522

Director acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WHITFIELD ROY A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-03-15 Exercise or conversion : show line 1 in the form +14,000 $8.37 $117,180 98,000 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-15 Exercise or conversion : show line 2 in the form Stock Option −14,000 $8.37 2017-09-14 14,000 0 D
Loading xslF345X03/doc4.xml…